\
&
Contact us
\
&
Contact us
Published on | 6 months ago
Programmes Digital Europe SemiconductorsThe Chips for Europe Initiative (the “Initiative”) is established by Pillar I of the European Chips Act for the
duration of the Multiannual Financial Framework 2021-2027. It aims to strengthen the EU's semiconductor
ecosystem, to boost competitiveness and achieve technological sovereignty.The implementation of the Initiative is designed in a way to pool resources from the Union, the Member States as well as the private sector. The total Union funding amounts to 3,3 billion EUR, which includes funding from Horizon Europe and from the Digital Europe Programme (DEP).
Knowledge of underlying EU policies and legislations is a key element in Digital Europe proposals as they play an important role in the “relevance” evaluation criterion. This Policy Briefing is one of several briefings prepared by DEP4ALL, the NCP Network for the Digital Europe programme, to support applicants with summaries of relevant EU initiatives.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
